For people who were blown away to learn recently that the 11 largest global pharmaceutical companies made an astonishing $711 billion in profits over the last decade, here's another measure of the industry's greed.
The private sector should be held to the same standard of scrutiny that the government itself receives from the people, and corporate governance should be as much a matter of public debate and law as political governance.
The high pay for those at the top does not come out of the air; it comes from everyone else's paycheck. There is no single policy that would reverse this enormous upward redistribution of income, but reining in CEO pay has to be an important part of the story.
Mary Jo White is touted as a former tough prosecutor with the ability to police Wall Street. She is at the top of her profession, with experience as a leading corporate defense attorney. And it is this very experience that raises questions as to whether she can and will do the job.
Congress continues its trend of dysfunction and paralysis even as many CEOs are making unprecedented money for delivering poor results. It's a paradox: why do we let failed leaders stick around well beyond their expiration dates?